Abdel Hadi Hamad, Eltayeb Faiha, Al Balushi Sara, Daghfal Joanne, Ahmed Faraz, Mateus Ceu
Communicable Diseases Centre, Hamad Medical Corporation, Doha P.O. Box 3050, Qatar.
Division of Health Research, Faculty of Health and Medicine, Lancaster University, Lancaster LA1 4YW, UK.
Antibiotics (Basel). 2024 Mar 12;13(3):253. doi: 10.3390/antibiotics13030253.
Antimicrobial Stewardship Programs (ASP) were introduced in healthcare as a public health priority to promote appropriate prescribing of antimicrobials, to reduce adverse events related to antimicrobials, as well as to control the escalating challenges of antimicrobial resistance. To deliver aimed outcome objectives, ASPs involve multiple connected implementation process measures. A systematic review was conducted to evaluate both concepts of ASPs. Guided by PRISMA frames, published systematic reviews (SR) focusing on ASPs restricted to secondary and tertiary healthcare were evaluated over the past 10 years involving all age groups. Out of 265 identified SR studies, 63 met the inclusion criteria. The majority were conducted in Europe and North America, with limited studies from other regions. In the reviewed studies, all age groups were examined, although they were conducted mainly on adults when compared to children and infants. Both process and outcomes measures of ASPs were examined equally and simultaneously through 25 different concepts, dominated by efficacy, antimicrobial resistance, and economic impact, while information technology as well as role of pharmacy and behavioral factors were equally examined. The main broad conclusions from the review were that, across the globe, ASPs demonstrated effectiveness, proved efficacy, and confirmed efficiency, while focused evaluation advocated that developed countries should target medium- and small-sized hospitals while developing countries should continue rolling ASPs across healthcare facilities. Additionally, the future of ASPs should focus on embracing evolving information technology to bridge the gaps in knowledge, skills, and attitude, as well as to enhance appropriate decision making.
抗菌药物管理计划(ASP)作为一项公共卫生重点措施被引入医疗保健领域,旨在促进抗菌药物的合理处方,减少与抗菌药物相关的不良事件,并应对抗菌药物耐药性不断升级的挑战。为实现既定的目标,ASP涉及多个相互关联的实施过程措施。我们进行了一项系统综述,以评估ASP的两个概念。在PRISMA框架的指导下,我们评估了过去10年发表的、聚焦于二级和三级医疗保健机构的、涉及所有年龄组的关于ASP的系统综述(SR)。在确定的265项SR研究中,63项符合纳入标准。大多数研究在欧洲和北美进行,其他地区的研究有限。在所审查的研究中,对所有年龄组都进行了检查,不过与儿童和婴儿相比,主要是针对成年人进行的。通过25个不同的概念,对等且同时检查了ASP的过程和结果指标,其中以疗效、抗菌药物耐药性和经济影响为主,同时对等检查了信息技术以及药学的作用和行为因素。该综述的主要广泛结论是,在全球范围内,ASP显示出有效性、已证实的疗效和效率,而重点评估表明,发达国家应将中小型医院作为目标,而发展中国家应继续在各医疗机构推广ASP。此外,ASP的未来应侧重于采用不断发展的信息技术,以弥合知识、技能和态度方面的差距,并加强适当的决策。